Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 8, Issue 12

June 25 2024

In this Issue

INSIDE BLOOD ADVANCES
SYSTEMATIC REVIEW
CLINICAL TRIALS AND OBSERVATIONS
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY AND IMMUNOTHERAPY
LYMPHOID NEOPLASIA
MYELOID NEOPLASIA
PLASMA CELL DISORDERS
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSFUSION MEDICINE
TRANSPLANTATION
RESEARCH LETTERS
COMMENTARY
ERRATA

INSIDE BLOOD ADVANCES

CAR T-cell expansion: harmful or helpful?

Anath C. Lionel,Sattva S. Neelapu

View Articletitled, CAR T-cell expansion: harmful or helpful?

Blood cell JAKtivation aggravates cerebral venous thrombosis

Brandi Reeves

View Articletitled, Blood cell JAKtivation aggravates cerebral venous thrombosis

SYSTEMATIC REVIEW

Machine learning natural language processing for identifying venous thromboembolism: systematic review and meta-analysis

Barbara D. Lam,Pavlina Chrysafi,Thita Chiasakul,Harshit Khosla,Dimitra Karagkouni,Megan McNichol,Alys Adamski,Nimia Reyes,Karon Abe,Simon Mantha,Ioannis S. Vlachos,Jeffrey I. Zwicker,Rushad Patell

View Articletitled, Machine learning natural language processing for identifying venous thromboembolism: systematic review and meta-analysis

Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

Tabelecleucel for EBV⁺ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol
Clinical Trials & Observations

Sarah Nikiforow,Jennifer S. Whangbo,Ran Reshef,Donald E. Tsai,Nancy Bunin,Rolla Abu-Arja,Kris Michael Mahadeo,Wen-Kai Weng,Koen Van Besien,David Loeb,Sunita Dwivedy Nasta,Eneida R. Nemecek,Weizhi Zhao,Yan Sun,Faith Galderisi,Justin Wahlstrom,Aditi Mehta,Laurence Gamelin,Rajani Dinavahi,Susan Prockop

View Articletitled, Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol

Supplemental data

Fanconi anemia neuroinflammatory syndrome: brain lesions and neurologic injury in Fanconi anemia
Clinical Trials & Observations

Allison L. Bartlett,John E. Wagner,Blaise Jones,Susanne Wells,Anthony Sabulski,Christine Fuller,Stella M. Davies

View Articletitled, Fanconi anemia neuroinflammatory syndrome: brain lesions and neurologic injury in Fanconi anemia

Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
Clinical Trials & Observations

Issam S. Hamadeh,Tala Shekarkhand,Colin Rueda,Ross S. Firestone,Alice X. Wang,Neha Korde,Malin L. Hultcrantz,Alexander M. Lesokhin,Sham Mailankody,Hani Hassoun,Urvi A. Shah,Kylee Maclachlan,Sridevi Rajeeve,Dhwani Patel,Gunjan L. Shah,Michael Scordo,Oscar B. Lahoud,David J. Chung,Heather J. Landau,Sergio Giralt,Saad Z. Usmani,Carlyn R. Tan

View Articletitled, Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome
Clinical Trials & Observations

V. Koneti Rao,Elaine Kulm,Jennifer Grossman,David Buchbinder,Hey Chong,Jason Bradt,Sharon Webster,Anna Šedivá,Virgil A. Dalm,Gulbu Uzel

View Articletitled, Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome

Supplemental data

Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101
Clinical Trials & Observations

Tracy T. Batchelor,Sharmila Giri,Amy S. Ruppert,Susan M. Geyer,Scott E. Smith,Nimish Mohile,Lode J. Swinnen,Jonathan W. Friedberg,Brad S. Kahl,Nancy L. Bartlett,Eric D. Hsi,Bruce D. Cheson,Nina Wagner-Johnston,Lakshmi Nayak,John P. Leonard,James L. Rubenstein

View Articletitled, Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101

Supplemental data

HEMATOPOIESIS AND STEM CELLS

Yin Yang 1 regulates cohesin complex protein SMC3 in mouse hematopoietic stem cells

Zhanping Lu,Yinghua Wang,Anna L. F. V. Assumpção,Peng Liu,Audrey Kopp,Sahitya Saka,Sean J. Mcilwain,Aaron D. Viny,Marjorie Brand,Xuan Pan

View Articletitled, Yin Yang 1 regulates cohesin complex protein SMC3 in mouse hematopoietic stem cells

Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Double-negative T cells utilize a TNFα–JAK1–ICAM-1 cytotoxic axis against acute myeloid leukemia

Enoch Tin,Jong Bok Lee,Ismat Khatri,Yoosu Na,Mark D. Minden,Li Zhang

View Articletitled, Double-negative T cells utilize a TNFα–JAK1–ICAM-1 cytotoxic axis against acute myeloid leukemia

Supplemental data

Postinfusion PD-1⁺ CD8⁺ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma

Nathan Denlinger,No-Joon Song,Xiaoli Zhang,Hyeongseon Jeon,Chelsea Peterson,Yi Wang,Kelsi Reynolds,Robert M. Bolz,Jessica Miao,Chunhua Song,Dayong Wu,Wing Keung Chan,Evandro Bezerra,Narendranath Epperla,Timothy J. Voorhees,Jonathan Brammer,Adam S. Kittai,David A. Bond,Yazeed Sawalha,Audrey Sigmund,John C. Reneau,Mark P. Rubinstein,Walter Hanel,Beth Christian,Robert A. Baiocchi,Kami Maddocks,Lapo Alinari,Sumithira Vasu,Marcos de Lima,Dongjun Chung,Samantha Jaglowski,Zihai Li,Xiaopei Huang,Yiping Yang

View Articletitled, Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma

Supplemental data

Dual role of signaling pathways in myeloma requires cell type–specific targeting of ligand-receptor interactions

Pablo Hernandez-Lopez,Tushara Vijaykumar,Praveen Anand,Daniel Auclair,Julia Frede,Birgit Knoechel,Jens G. Lohr

View Articletitled, Dual role of signaling pathways in myeloma requires cell type–specific targeting of ligand-receptor interactions

Supplemental data

LYMPHOID NEOPLASIA

Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma

Ying Liu,Rohan Sardana,David Nemirovsky,Denise Frosina,Achim Jungbluth,William T. Johnson,Santosha Vardhana,Maria Arcila,Steven M. Horwitz,Andriy Derkach,Ahmet Dogan,Wenbin Xiao

View Articletitled, Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma

Supplemental data

Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression

Léa Fléchon,Inès Arib,Ankit K. Dutta,Lama Hasan Bou Issa,Romanos Sklavenitis-Pistofidis,Rémi Tilmont,Chip Stewart,Romain Dubois,Stéphanie Poulain,Marie-Christine Copin,Sahir Javed,Morgane Nudel,Doriane Cavalieri,Guillaume Escure,Nicolas Gower,Paul Chauvet,Nicolas Gazeau,Cynthia Saade,Marietou Binta Thiam,Aïcha Ouelkite-Oumouchal,Silvia Gaggero,Émeline Cailliau,Sarah Faiz,Olivier Carpentier,Nicolas Duployez,Thierry Idziorek,Laurent Mortier,Martin Figeac,Claude Preudhomme,Bruno Quesnel,Suman Mitra,Franck Morschhauser,Gad Getz,Irene M. Ghobrial,Salomon Manier

View Articletitled, Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression

Supplemental data

Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL

Yaqi Zhao,A. Douglas Laird,Kathryn G. Roberts,Rolla Yafawi,Hagop Kantarjian,Daniel J. DeAngelo,Matthias Stelljes,Michaela Liedtke,Wendy Stock,Nicola Gökbuget,Susan O’Brien,Elias Jabbour,Ryan D. Cassaday,Melanie R. Loyd,Scott Olsen,Geoffrey Neale,Xueli Liu,Erik Vandendries,Anjali Advani,Charles G. Mullighan

View Articletitled, Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL

Supplemental data

CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity
Clinical Trials & Observations

Mark P. Hamilton,Erin Craig,Cesar Gentille Sanchez,Alain Mina,John Tamaresis,Nadia Kirmani,Zachary Ehlinger,Shriya Syal,Zinaida Good,Brian Sworder,Joseph Schroers-Martin,Ying Lu,Lori Muffly,Robert S. Negrin,Sally Arai,Robert Lowsky,Everett Meyer,Andrew R. Rezvani,Judith Shizuru,Wen-Kai Weng,Parveen Shiraz,Surbhi Sidana,Sushma Bharadwaj,Melody Smith,Saurabh Dahiya,Bita Sahaf,David M. Kurtz,Crystal L. Mackall,Robert Tibshirani,Ash A. Alizadeh,Matthew J. Frank,David B. Miklos

View Articletitled, CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity

Supplemental data

MYELOID NEOPLASIA

Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trial

Genki Yamato,Yusuke Tsumura,Hideki Muramatsu,Akira Shimada,Takahiro Imaizumi,Hiroyuki Tsukagoshi,Taeko Kaburagi,Norio Shiba,Yoshiyuki Yamada,Takao Deguchi,Tomoko Kawai,Kiminori Terui,Etsuro Ito,Kenichiro Watanabe,Yasuhide Hayashi

View Articletitled, Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trial

Supplemental data

The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance

Marissa Li,Anmol Baranwal,Mark Gurney,Syed N. Shah,Aref Al-Kali,Hassan Alkhateeb,James Foran,Cecilia Arana Yi,Laura Ongie,Dong Chen,Abhishek Mangaonkar,Kristen McCullough,Ayalew Tefferi,Terra Lasho,Christy Finke,Mrinal M. Patnaik,Mithun Vinod Shah

View Articletitled, The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance

Supplemental data

Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia

Romy E. van Weelderen,Christine J. Harrison,Kim Klein,Yilin Jiang,Jonas Abrahamsson,Todd Alonzo,Richard Aplenc,Nira Arad-Cohen,Emmanuelle Bart-Delabesse,Barbara Buldini,Barbara De Moerloose,Michael N. Dworzak,Sarah Elitzur,José M. Fernández Navarro,Alan Gamis,Robert B. Gerbing,Bianca F. Goemans,Hester A. de Groot-Kruseman,Erin Guest,Shau-Yin Ha,Henrik Hasle,Charikleia Kelaidi,Hélène Lapillonne,Guy Leverger,Franco Locatelli,Takako Miyamura,Ulrika Norén-Nyström,Sophia Polychronopoulou,Mareike Rasche,Jeffrey E. Rubnitz,Jan Stary,Anne Tierens,Daisuke Tomizawa,C. Michel Zwaan,Gertjan J. L. Kaspers

View Articletitled, Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia

Supplemental data

A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML

Zhiyao Ren,Jolien Vanhooren,Charlotte Derpoorter,Barbara De Moerloose,Tim Lammens

View Articletitled, A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML

Supplemental data

PLASMA CELL DISORDERS

Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies

Anna J. Howard,Isabel Concepcion,Alice X. Wang,Issam S. Hamadeh,Malin Hultcrantz,Sham Mailankody,Carlyn Tan,Neha Korde,Alexander M. Lesokhin,Hani Hassoun,Urvi A. Shah,Kylee H. Maclachlan,Sridevi Rajeeve,Heather J. Landau,Michael Scordo,Gunjan L. Shah,Oscar B. Lahoud,David J. Chung,Sergio Giralt,Saad Z. Usmani,Ross S. Firestone

View Articletitled, Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies

Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Biased agonism of protease-activated receptor-1 regulates thromboinflammation in murine sickle cell disease

Nirupama Ramadas,Kailyn Lowder,Joshua Dutton,Fatima Trebak,Camille Faes,John H. Griffin,Rafal Pawlinski,Laurent O. Mosnier,Erica Sparkenbaugh

View Articletitled, Biased agonism of protease-activated receptor-1 regulates thromboinflammation in murine sickle cell disease

Supplemental data

THROMBOSIS AND HEMOSTASIS

Plasma kallikrein supports FXII-independent thrombin generation in mouse whole blood

Jun Wan,Sophia Dhrolia,Rohan R. Kasthuri,Yuriy Prokopenko,Anton Ilich,Prakash Saha,Mark Roest,Alisa S. Wolberg,Nigel S. Key,Rafal Pawlinski,Pavan K. Bendapudi,Nigel Mackman,Steven P. Grover

View Articletitled, Plasma kallikrein supports FXII-independent thrombin generation in mouse whole blood

Supplemental data

Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women
Clinical Trials & Observations

Ellen Zhang,Zain M. Virk,Josanna Rodriguez-Lopez,Hanny Al-Samkari

View Articletitled, Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women

Supplemental data

Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for optimal hospital VTE prophylaxis

Benjamin Djulbegovic,Alice Boylan,Shelby Kolo,Danielle Bowen Scheurer,Sydney Anuskiewicz,Flora Khaledi,Kimberley Youkhana,Sarah Madgwick,Neema Maharjan,Iztok Hozo

View Articletitled, Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for optimal hospital VTE prophylaxis

Supplemental data

O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies

Ellie Karampini,Dearbhla Doherty,Petra E. Bürgisser,Massimiliano Garre,Ingmar Schoen,Stephanie Elliott,Ruben Bierings,James S. O’Donnell

View Articletitled, O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies

Exacerbation of thromboinflammation by JAK2^V617F mutation worsens the prognosis of cerebral venous sinus thrombosis

Marie-Charlotte Bourrienne,Véronique Le Cam Duchez,Dorothée Faille,Carine Farkh,Mialitiana Solo Nomenjanahary,Juliette Gay,Stéphane Loyau,Clément Journé,Sébastien Dupont,Véronique Ollivier,Jean-Luc Villeval,Isabelle Plo,Valérie Edmond,Martine Jandrot-Perrus,Sylvie Labrouche-Colomer,Bruno Cassinat,Emmanuelle Verger,Jean-Philippe Desilles,Benoît Ho-Tin-Noé,Aude Triquenot Bagan,Mikaël Mazighi,Nadine Ajzenberg,on behalf of the FPCCVT Study Group

View Articletitled, Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis

Supplemental data

TRANSFUSION MEDICINE

Integrated analyses reveal unexpected complex inversion and recombination in RH genes

Minghao Li,Liping Wang,Aijing Li,Bo Wang,Xiaohong Yang,Yue Zhang,Chaoqiong Chen,Futing Sun,Ziyan Zhu,Luyi Ye

View Articletitled, Integrated analyses reveal unexpected complex inversion and recombination in RH genes

Supplemental data

TRANSPLANTATION

Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies

Supawee Saengboon,Stefan Ciurea,Uday Popat,Jeremy Ramdial,Qaiser Bashir,Amin Alousi,Julianne Chen,Gabriela Rondon,Amanda Olson,Jin Im,Chitra Hosing,Elizabeth Shpall,Richard Champlin,Samer A. Srour

View Articletitled, Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies

Supplemental data

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

Aaron Etra,Najla El Jurdi,Nikolaos Katsivelos,Deukwoo Kwon,Stephanie Gergoudis,George Morales,Nikolaos Spyrou,Steven Kowalyk,Paibel Aguayo-Hiraldo,Yu Akahoshi,Francis Ayuk,Janna Baez,Brian C. Betts,Chantiya Chanswangphuwana,Yi-Bin Chen,Hannah Choe,Zachariah DeFilipp,Sigrun Gleich,Elizabeth Hexner,William J. Hogan,Ernst Holler,Carrie L. Kitko,Sabrina Kraus,Monzr Al Malki,Margaret MacMillan,Attaphol Pawarode,Francesco Quagliarella,Muna Qayed,Ran Reshef,Tal Schechter,Ingrid Vasova,Daniel Weisdorf,Matthias Wölfl,Rachel Young,Ryotaro Nakamura,James L. M. Ferrara,John E. Levine,Shernan Holtan

View Articletitled, Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

Supplemental data

RESEARCH LETTERS

Thrombocytosis and megakaryocyte changes associated with PRCA

Joelle Abdallah,Robert George Williams,Hussein Awada,Ganesh Raman,Yusuf Ozcan,Mark Orland,Mutlu Mete,Weina Chen,Carmelo Gurnari,Jaroslaw P. Maciejewski,Taha Bat

View Articletitled, Thrombocytosis and megakaryocyte changes associated with PRCA

Impact of arginine therapy on kyotorphin in children with sickle cell disease and vaso-occlusive pain
Clinical Trials & Observations

Rawan Korman,Dunia Hatabah,Lou Ann Brown,Frank Harris,Hagar Wilkinson,Chris A. Rees,Nitya Bakshi,David R. Archer,Carlton Dampier,Claudia R. Morris

View Articletitled, Impact of arginine therapy on kyotorphin in children with sickle cell disease and vaso-occlusive pain

Supplemental data

Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms

Thibault Mahévas,Amélie Osio,Lise Larcher,Emmanuelle Clappier,Werner Kempf,Lionel Adès,Pierre Fenaux,Marie Sébert,Jérémie Delaleu,Marie Jachiet,Florence Cordoliani,Estelle Charvet,Olivier Carpentier,Raphael Itzykson,Marie Weinborn,Nicoleta Mardare,Joséfina Marco-Bonnet,Adèle De Masson,Nicolas Duployez,Tony Martial Huynh,Jean-David Bouaziz,Marie-Dominique Vignon-Pennamen,Maxime Battistella

View Articletitled, Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms

COMMENTARY

TLR7 signaling: a central nexus in autoimmunity and cGVHD

Ranjeet Singh Mahla

View Articletitled, TLR7 signaling: a central nexus in autoimmunity and cGVHD

ERRATA

Bala NS, Stanek JR, Vesely SK, et al. Comparison of thromboembolism outcomes in patients with sickle cell disease prescribed hormonal contraception. Blood Adv. 2023;7(20):6140-6150.

View Articletitled, Bala NS, Stanek JR, Vesely SK, et al. Comparison of thromboembolism outcomes in patients with sickle cell disease prescribed hormonal contraception. Blood Adv. 2023;7(20):6140-6150.

Al Tabaa Y, Casasnovas RO, Baillet C, et al. Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group. Blood Adv. 2023;7(14):3735-3738.

View Articletitled, Al Tabaa Y, Casasnovas RO, Baillet C, et al. Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group. Blood Adv. 2023;7(14):3735-3738.

Cover Image

Cover Image

Three-dimensional model showing the amino acid changes of several representative missense mutations in FAS protein. See the article by Liu et al.

All Issues

Advertisement intended for health care professionals

Email alerts

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read
Most Cited

Time to revisit reduced-dose radiotherapy for PCNSL?

Lin A, Brown S, Chinapen S, et al. Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant. Blood Adv. 2023;7(23):7153-7160.

Jalink M, Jacobs CF, Khwaja J, et al. Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood Adv. 2024;8(11):2622-2634.

Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes

Retreatment of multiple myeloma with previously refractory drugs

Advertisement intended for health care professionals

Issue Archive

Table of Contents

INSIDE BLOOD ADVANCES

SYSTEMATIC REVIEW

CLINICAL TRIALS AND OBSERVATIONS

Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol Clinical Trials & Observations

Fanconi anemia neuroinflammatory syndrome: brain lesions and neurologic injury in Fanconi anemia Clinical Trials & Observations

Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy Clinical Trials & Observations

Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome Clinical Trials & Observations

Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101 Clinical Trials & Observations

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY AND IMMUNOTHERAPY

LYMPHOID NEOPLASIA

CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity Clinical Trials & Observations

MYELOID NEOPLASIA

PLASMA CELL DISORDERS

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS

Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women Clinical Trials & Observations

TRANSFUSION MEDICINE

TRANSPLANTATION

RESEARCH LETTERS

Impact of arginine therapy on kyotorphin in children with sickle cell disease and vaso-occlusive pain Clinical Trials & Observations

COMMENTARY

ERRATA

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

Tabelecleucel for EBV⁺ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol
Clinical Trials & Observations

Fanconi anemia neuroinflammatory syndrome: brain lesions and neurologic injury in Fanconi anemia
Clinical Trials & Observations

Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
Clinical Trials & Observations

Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome
Clinical Trials & Observations

Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101
Clinical Trials & Observations

CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity
Clinical Trials & Observations

Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women
Clinical Trials & Observations

Impact of arginine therapy on kyotorphin in children with sickle cell disease and vaso-occlusive pain
Clinical Trials & Observations